Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Jovitta Jacob"'
Autor:
Hagop Kantarjian, Fadi G. Haddad, Nitin Jain, Koji Sasaki, Nicholas J. Short, Sanam Loghavi, Rashmi Kanagal-Shamanna, Jeffrey Jorgensen, Issa Khouri, Partow Kebriaei, Yesid Alvarado, Tapan Kadia, Shilpa Paul, Guillermo Garcia-Manero, Bouthaina Dabaja, Musa Yilmaz, Jovitta Jacob, Rebecca Garris, Susan O’Brien, Farhad Ravandi, Elias Jabbour
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background Historically, adults with relapsed-refractory acute lymphoblastic leukemia (ALL) experienced poor outcomes with intensive chemotherapy. This mature analysis explores the benefit of the addition of sequential blinatumomab to low-in
Externí odkaz:
https://doaj.org/article/b4f44ab39b2049e6b4e01db67dec5fb5
Autor:
Fadi Haddad, Elias Jabbour, Cedric Nasnas, Nicholas Short, Walid Macaron, Marianne Zoghbi, Lewis Nasr, Nitin Jain, Emmanuel Almanza, Koji Sasaki, Farhad Ravandi, Partow Kebriaei, Xuelin Huang, Guillermo Garcia-Manero, Tapan Kadia, Sa Wang, Jovitta Jacob, Rebecca Garris, Susan O’brien, Hagop Kantarjian
Publikováno v:
HemaSphere, Vol 7, p e89468e9 (2023)
Externí odkaz:
https://doaj.org/article/2371953e00b2466db3b1efe503260c07
Autor:
Fadi Haddad, Elias Jabbour, Cedric Nasnas, Nicholas Short, Lewis Nasr, Walid Macaron, Marianne Zoghbi, Farhad Ravandi, Nitin Jain, Tapan Kadia, Naval Daver, Gautam Borthakur, Courtney Dinardo, Jovitta Jacob, Edith Roy, Christopher Loiselle, Anna Milton, Juan Rivera, Rebecca Garris, Hagop Kantarjian
Publikováno v:
HemaSphere, Vol 7, p e3563066 (2023)
Externí odkaz:
https://doaj.org/article/66b50c3004494c4eaadc9f9e757ab8e5
Autor:
Fadi Haddad, Elias Jabbour, Nicholas Short, Nitin Jain, Emmanuel Almanza Huante, Koji Sasaki, Patrice Nasnas, Farhad Ravandi, Partow Kebriaei, Xuelin Huang, Marina Konopleva, Guillermo Garcia-Manero, Richard E Champlin, Tapan M. Kadia, Koichi Takahashi, Naval Daver, Joseph D. Khoury, Jeffrey L. Jorgensen, Sa A Wang, Jovitta Jacob, Rebecca Garris, Hagop Kantarjian
Publikováno v:
Blood. 140:11698-11701
Autor:
Elias Jabbour, Nicholas J Short, Jayastu Senapati, Nitin Jain, Xuelin Huang, Naval Daver, Courtney D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia-Manero, Guillermo Montalban Bravo, Koji Sasaki, Tapan M Kadia, Joseph Khoury, Sa A Wang, Fadi G Haddad, Jovitta Jacob, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Publikováno v:
The Lancet Haematology.
Autor:
Jayastu Senapati, Nicholas Short, Yesid Alvarado, Jan A. Burger, Nitin Jain, Marina Konopleva, Farhad Ravandi, Courtney D. DiNardo, Lucia Masarova, Koji Sasaki, Philip A. Thompson, Alessandra Ferrajoli, Jovitta Jacob, Ejiroghene Mayor, Anna Milton, Christopher Loiselle, Rebecca Garris, Hagop Kantarjian, Elias Jabbour
Publikováno v:
Blood. 140:3253-3255
Autor:
Jeffrey L. Jorgensen, William G. Wierda, Nitin Jain, Partow Kebriaei, Naval Daver, Nicholas J. Short, Issa F. Khouri, Jovitta Jacob, Susan O'Brien, Hind Rafei, Joseph D. Khoury, Richard E. Champlin, Xuelin Huang, Rebecca Garris, Courtney D. DiNardo, Elias Jabbour, Ghayas C. Issa, Rita Khouri, Koji Sasaki, Hagop M. Kantarjian, Farhad Ravandi, Patrice Nasnas, Guillermo Montalban-Bravo, Sa A. Wang, Guillermo Garcia-Manero, Nadya Jammal, Philip A. Thompson, Naveen Pemmaraju, Marina Konopleva, Bouthaina S. Dabaja, Tapan M. Kadia, Shilpa Paul, Meagan Rostykus
Publikováno v:
Blood. 136:39-41
Background: The combination of low intensity therapy with mini-hyper-CVD and INO with or without Blina has led to significant improvement in survival and outcomes of pts with R-R ALL. ASCT following salvage therapy is considered standard of care in p
Autor:
Naveen Pemmaraju, William G. Wierda, Jan A. Burger, Marina Konopleva, Monica Kwari, Susan O'Brien, Nitin Jain, Joseph D. Khoury, Elias Jabbour, Steven M. Kornblau, Sa A. Wang, Anna Milton, Jeffrey L. Jorgensen, Rebecca Garris, Juan Rivera, Meagan Rostykus, Farhad Ravandi, Xuelin Huang, Tapan M. Kadia, Christopher Loiselle, Guillermo Garcia-Manero, Gautam Borthakur, Naval Daver, Hagop M. Kantarjian, Yesid Alvarado, Courtney D. DiNardo, Caitlin R. Rausch, Nicholas J. Short, Jovitta Jacob
Publikováno v:
Blood. 136:15-17
Background: Inotuzumab ozogamicin (INO) and blinatumomab both improve overall survival (OS) in relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Use of these effective monoclonal antibodies in the frontline setting may lead to deep an
Autor:
Rebecca Garris, Koichi Takahashi, Joseph D. Khoury, Jovitta Jacob, Tapan M. Kadia, Hagop M. Kantarjian, Nitin Jain, Maria Khouri, Nicholas J. Short, Hind Rafei, Xuelin Huang, Partow Kebriaei, Sa A. Wang, Koji Sasaki, Farhad Ravandi, Richard E. Champlin, Guillermo Garcia-Manero, Elias Jabbour, Susan O'Brien, Jeffrey L. Jorgensen, Marina Konopleva
Publikováno v:
Blood. 136:2-4
Background: The combination of low-intensity therapy (mini-hyper-CVD) with inotuzumab ozogamicin with or without sequential blinatumomab is effective in patients with relapsed/refractory Philadelphia-chromosome negative acute lymphoblastic leukemia (
Autor:
Sa A. Wang, Susan O'Brien, Joseph D. Khoury, Jeffrey L. Jorgensen, Guillermo Garcia-Manero, Jovitta Jacob, Partow Kebriaei, Koichi Takahashi, William G. Wierda, Bouthaina S. Dabaja, Srdan Verstovsek, Farhad Ravandi, Marina Konopleva, Nitin Jain, Patrice Nasnas, Courtney D. DiNardo, Koji Sasaki, Musa Yilmaz, Monica Kwari, C. Cameron Yin, Issa F. Khouri, Rebecca Garris, Guillermo Montalban-Bravo, Elias Jabbour, Xuelin Huang, Caitlin R. Rausch, Meagan Rostykus, Tapan M. Kadia, Naval Daver, Shilpa Paul, Hind Rafei, Nicholas J. Short, Rita Khouri, Hagop M. Kantarjian
Publikováno v:
Blood. 136:45-47
Background: The combination of INO with hyper-mini-CVD with or without blinatumomab offers a safe and effective treatment modality for pts with R-R ALL. However, the outcomes of some pts remain poor and the predictors of survival are not well underst